MIST Milestone posts wider than expected Q4 2025 loss even as shares edge higher in daily trading Is Amneal AMRX stock testing support Amneal posts 557 pct EPS beat vs street estimates How Octave OSG balances growth with profitability Technical Weakness 20260506 Why CompX CIX guidance matters more than actual results